140 related articles for article (PubMed ID: 34339121)
1. Pathogenesis of Avian Influenza Virus Subtype H9N2 in Turkeys and Evaluation of Inactivated Vaccine Efficacy.
Fellahi S; Nassik S; Maaroufi I; Tligui NS; Touzani CD; Rawi T; Delvecchio A; Ducatez MF; Houadfi ME
Avian Dis; 2021 Mar; 65(1):46-51. PubMed ID: 34339121
[TBL] [Abstract][Full Text] [Related]
2. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
[TBL] [Abstract][Full Text] [Related]
3. Immunization of turkeys with a DNA vaccine expressing the haemagglutinin gene of low pathogenic avian influenza virus subtype H9N2.
Shehata AA; Basiouni S; Ali A; Fawzy M; Hafez HM; Ulbert S; Vahlenkamp T
J Virol Methods; 2020 Oct; 284():113938. PubMed ID: 32663531
[TBL] [Abstract][Full Text] [Related]
4. Co-infections of chickens with avian influenza virus H9N2 and Moroccan Italy 02 infectious bronchitis virus: effect on pathogenesis and protection conferred by different vaccination programmes.
Belkasmi SFZ; Fellahi S; Touzani CD; Faraji FZ; Maaroufi I; Delverdier M; Guérin JL; Fihri OF; El Houadfi M; Ducatez MF
Avian Pathol; 2020 Feb; 49(1):21-28. PubMed ID: 31412705
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vaccination on Distribution and Immune Response of Avian Influenza Virus H9N2 in Coturnix coturnix.
Golgol E; Mayahi M; Boroomand Z; Shoshtari A
Arch Razi Inst; 2023 Dec; 78(6):1746-1752. PubMed ID: 38828164
[TBL] [Abstract][Full Text] [Related]
7. Enhanced infection of avian influenza virus H9N2 with infectious laryngeotracheitis vaccination in chickens.
Arafat N; Eladl AH; Marghani BH; Saif MA; El-Shafei RA
Vet Microbiol; 2018 Jun; 219():8-16. PubMed ID: 29778208
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
[TBL] [Abstract][Full Text] [Related]
9. Trend of Changes in the Titer of Antibody against Avian Influenza Virus H9n2 during Raising Period in Vaccinated and Unvaccinated Broiler Farms in Qazvin Province, Iran: A Cohort Study.
Mirzaiee K; Shoushtari A; Bokaie S; Fallah Mehrabadi MH; Peighambari SM
Arch Razi Inst; 2020 Mar; 75(1):9-16. PubMed ID: 32291997
[TBL] [Abstract][Full Text] [Related]
10. Protective Efficacy Evaluation of Four Inactivated Commercial Vaccines Against Low Pathogenic Avian Influenza H9N2 Virus Under Experimental Conditions in Broiler Chickens.
Khantour AE; Houadfi ME; Nassik S; Tligui NS; Mellouli FE; Sikht FZ; Ducatez MF; Soulaymani A; Fellahi S
Avian Dis; 2021 Sep; 65(3):351-357. PubMed ID: 34427407
[TBL] [Abstract][Full Text] [Related]
11. Vaccine Protection of Turkeys Against H5N1 Highly Pathogenic Avian Influenza Virus with a Recombinant Turkey Herpesvirus Expressing the Hemagglutinin Gene of Avian Influenza.
Kapczynski DR; Dorsey K; Chrzastek K; Moraes M; Jackwood M; Hilt D; Gardin Y
Avian Dis; 2016 Jun; 60(2):413-7. PubMed ID: 27309280
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
Zhao J; Yang H; Xu H; Ma Z; Zhang G
Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
[TBL] [Abstract][Full Text] [Related]
13. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
[TBL] [Abstract][Full Text] [Related]
14. Role of aflatoxin toxicity on transmissibility and pathogenicity of H9N2 avian influenza virus in turkeys.
Umar S; Younus M; Muti Ur Rehman ; Aslam A; Shah MA; Munir MT; Hussain S; Iqbal F; Fiaz M; Ullah S
Avian Pathol; 2015; 44(4):305-10. PubMed ID: 25932659
[TBL] [Abstract][Full Text] [Related]
15. Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus.
Kapczynski DR; Sylte MJ; Killian ML; Torchetti MK; Chrzastek K; Suarez DL
Vet Immunol Immunopathol; 2017 Sep; 191():74-79. PubMed ID: 28895870
[TBL] [Abstract][Full Text] [Related]
16. A Turkey-origin H9N2 Avian Influenza Virus Shows Low Pathogenicity but Different Within-Host Diversity in Experimentally Infected Turkeys, Quail and Ducks.
Świętoń E; Tarasiuk K; Olszewska-Tomczyk M; Iwan E; Śmietanka K
Viruses; 2020 Mar; 12(3):. PubMed ID: 32188100
[TBL] [Abstract][Full Text] [Related]
17. Avian Influenza-Killed Vaccine on Tissue Distribution and Shedding of Avian Influenza Virus H9N2 in Ducklings.
Abdi HM; Mayahi M; Boroomand Z; Shoshtari A
Arch Razi Inst; 2021; 76(3):437-444. PubMed ID: 34824737
[TBL] [Abstract][Full Text] [Related]
18. Vaccine Efficacy Against a New Avian Influenza (H9N2) Field Isolate from the Middle East (Serology and Challenge Studies).
Gharaibeh S; Amareen S
Avian Dis; 2015 Dec; 59(4):508-11. PubMed ID: 26629624
[TBL] [Abstract][Full Text] [Related]
19. Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not.
Naguib MM; Grund C; Arafa AS; Abdelwhab EM; Beer M; Harder TC
J Gen Virol; 2017 Jun; 98(6):1169-1173. PubMed ID: 28590242
[TBL] [Abstract][Full Text] [Related]
20. Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection.
Park JK; Lee DH; Cho CH; Yuk SS; To EO; Kwon JH; Noh JY; Kim BY; Choi SW; Shim BS; Song MK; Lee JB; Park SY; Choi IS; Song CS
Vet Microbiol; 2014 Mar; 169(3-4):211-7. PubMed ID: 24472228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
